Literature DB >> 19005627

Use of hand-held dynamometry in the evaluation of lower limb muscle strength in people with Huntington's disease.

Monica E Busse1, Gareth Hughes, Charles M Wiles, Anne E Rosser.   

Abstract

PURPOSE: Sub-clinical muscle involvement, including myopathic changes and mitochondrial dysfunction of skeletal muscle, has been reported in people with Huntington's disease (HD). Muscle strength was evaluated using a hand-held dynamometer. Reliability and validity in people with HD were determined.
METHOD: Isometric muscle strength of 6 lower limb muscle groups was measured in 20 people with HD and matched healthy controls. People with HD were evaluated with the Unified Huntington's Disease Rating Scales (UHDRS). Within session reliability using intra-class correlation coefficients (ICC) was calculated. Discriminant and convergent validity was also evaluated.
RESULTS: UHDRS motor scores of people with HD ranged from 28 to 80. Reliability of strength testing was excellent (ICC 0.86 to 0.98). People with HD had on average about half the strength of healthy matched controls. UHDRS motor scores and strength scores were significantly correlated (convergent) providing a further indication of validity of strength testing.
CONCLUSIONS: The hand-held dynamometer is a reliable and valid measurement tool to detect strength differences between people with HD and a matched control group. There is significant reduction in lower limb muscle strength in HD which does not appear to have been described previously.

Entities:  

Mesh:

Year:  2008        PMID: 19005627     DOI: 10.1007/s00415-008-0964-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

1.  Quantified measurement of activity provides insight into motor function and recovery in neurological disease.

Authors:  M E Busse; O R Pearson; R Van Deursen; C M Wiles
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

2.  Quantitative motor assessment in amyotrophic lateral sclerosis.

Authors:  P L Andres; W Hedlund; L Finison; T Conlon; M Felmus; T L Munsat
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

3.  Test-retest reliability of hand-held dynamometry during a single session of strength assessment.

Authors:  R W Bohannon
Journal:  Phys Ther       Date:  1986-02

Review 4.  Effects of age and training on skeletal muscle physiology and performance.

Authors:  L V Thompson
Journal:  Phys Ther       Date:  1994-01

5.  The measurement of muscle strength in patients with peripheral neuromuscular disorders.

Authors:  C M Wiles; Y Karni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-11       Impact factor: 10.154

6.  Accuracy, reproducibility, and variability of hand-held dynamometry in motor neuron disease.

Authors:  A Goonetilleke; H Modarres-Sadeghi; R J Guiloff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

7.  Coordination of prehensile forces during precision grip in Huntington's disease.

Authors:  A M Gordon; L Quinn; R Reilmann; K Marder
Journal:  Exp Neurol       Date:  2000-05       Impact factor: 5.330

8.  Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease.

Authors:  Carsten Saft; Jochen Zange; Jürgen Andrich; Klaus Müller; Katrin Lindenberg; Bernhard Landwehrmeyer; Matthias Vorgerd; Peter H Kraus; Horst Przuntek; Ludger Schöls
Journal:  Mov Disord       Date:  2005-06       Impact factor: 10.338

9.  Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation.

Authors:  Richard R Ribchester; Derek Thomson; Nigel I Wood; Tim Hinks; Thomas H Gillingwater; Thomas M Wishart; Felipe A Court; A Jennifer Morton
Journal:  Eur J Neurosci       Date:  2004-12       Impact factor: 3.386

Review 10.  Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD).

Authors:  N Quinn; R Brown; D Craufurd; S Goldman; J Hodges; K Kieburtz; O Lindvall; J MacMillan; R Roos
Journal:  Mov Disord       Date:  1996-03       Impact factor: 10.338

View more
  32 in total

1.  Fat-free mass and its predictors in Huntington's disease.

Authors:  S D Süssmuth; V M Müller; C Geitner; G B Landwehrmeyer; S Iff; A Gemperli; Michael Orth
Journal:  J Neurol       Date:  2015-04-23       Impact factor: 4.849

2.  Between-rater reliability of the 6-minute walk test, berg balance scale, and handheld dynamometry in people with multiple sclerosis.

Authors:  Elaine Toomey; Susan Coote
Journal:  Int J MS Care       Date:  2013

3.  The Expanding Clinical Universe of Polyglutamine Disease.

Authors:  Shanshan Huang; Suiqiang Zhu; Xiao-Jiang Li; Shihua Li
Journal:  Neuroscientist       Date:  2019-01-07       Impact factor: 7.519

4.  Mechanisms of altered skeletal muscle action potentials in the R6/2 mouse model of Huntington's disease.

Authors:  Daniel R Miranda; Eric Reed; Abdulrahman Jama; Michael Bottomley; Hongmei Ren; Mark M Rich; Andrew A Voss
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-20       Impact factor: 4.249

5.  Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's disease.

Authors:  Sydney R Coffey; Robert M Bragg; Shawn Minnig; Seth A Ament; Jeffrey P Cantle; Anne Glickenhaus; Daniel Shelnut; José M Carrillo; Dominic D Shuttleworth; Julie-Anne Rodier; Kimihiro Noguchi; C Frank Bennett; Nathan D Price; Holly B Kordasiewicz; Jeffrey B Carroll
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

6.  Depressed Synaptic Transmission and Reduced Vesicle Release Sites in Huntington's Disease Neuromuscular Junctions.

Authors:  Ahmad Khedraki; Eric J Reed; Shannon H Romer; Qingbo Wang; William Romine; Mark M Rich; Robert J Talmadge; Andrew A Voss
Journal:  J Neurosci       Date:  2017-07-19       Impact factor: 6.167

7.  Huntington disease skeletal muscle is hyperexcitable owing to chloride and potassium channel dysfunction.

Authors:  Christopher W Waters; Grigor Varuzhanyan; Robert J Talmadge; Andrew A Voss
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

8.  Psychometric Properties of a Clinical Strength Assessment Protocol in People with Multiple Sclerosis.

Authors:  Mark M Mañago; Jeffrey R Hebert; Margaret Schenkman
Journal:  Int J MS Care       Date:  2017 Sep-Oct

9.  Huntington's Disease-Induced Cardiac Disorders Affect Multiple Cellular Pathways.

Authors:  Girish C Melkani
Journal:  React Oxyg Species (Apex)       Date:  2016-09

10.  Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.

Authors:  Hilary Moffitt; Graham D McPhail; Ben Woodman; Carl Hobbs; Gillian P Bates
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.